Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

AnHeart receives clinical trial authorization for taletrectinib in China

March 24, 2020

BET on BD1 for cancer, BD2 for inflammation

March 24, 2020

WEG-232 reduces erlotinib-induced facial rash and hair loss in rats

March 23, 2020

DB-020 demonstrates promising safety and PK in healthy subjects

March 23, 2020

Shattuk Labs describes new chimeric proteins for cancer

March 23, 2020

Korean researchers identify NONO inhibitors

March 23, 2020

GlaxoSmithKline patents new BRD4 inhibitors

March 23, 2020

Positive topline data for pivotal phase III FLASH study of SGX-301

March 20, 2020

New IRAK-4 inhibitors identified at Zhejiang Hisun Pharmaceutical

March 20, 2020

Jiangsu Chia Tai Tianqing Pharmaceutical Group, Medshine Discovery describe drugs targeting CRBN

March 20, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...